Psychedelic Science — Past, Present & Future with Rick Doblin
In Drugreporter’s interview from Psychedelic Science 2025, Rick Doblin looks back on four decades of psychedelic activism and discusses the future after the FDA’s MDMA therapy rejection.
ETHAN NADELMANN: The progress on psychedelics creates momentum for broader drug policy reform
At ICPR 2024, we spoke with Ethan Nadelmann, founder of the Drug Policy Alliance, about how psychedelics fit into the broader landscape of drug policy reform.
The Need for a Consciousness Culture: Interview with Thomas Metzinger
In this thought-provoking conversation, Prof. Dr. Thomas Metzinger, a leading philosopher of mind and consciousness, examines the profound potential — and serious risks — of psychedelics.
Offering Support to the Survivors of October 7th
We interviewed Israeli psychotherapist Nir Tadmor about how he supported survivors of the Nova festival massacre and the deep emotional impact the tragedy had on the community.
The Shadow of the Psychedelic Movement: An Interview with Erik Davis
In this interview, we talk with Erik Davis about the forgotten shadows of psychedelic history, the need for cultural memory, and the deeper meanings hidden within blotter art.
What Octopuses Teach Us About MDMA: Our Interview With Gül Dölen
Psychedelics are the master keys to unlocking hidden potentials in our brains, claims Gül Dölen, a Turkish-American neuroscientist and professor at UC Berkeley. Please watch and share Drugreporter’s interview, filmed at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2024 in Haarlem, The Netherlands.
Coca, Harm Reduction, and Reconciliation – An Interview with Diego Andrés Lugo-Vivas
At the 28th Harm Reduction International Conference, we spoke with Diego Andrés Lugo-Vivas about the impact of the Drug War in Colombia and how the philosophy of harm reduction could be applied to the coca leaf. Watch the video!
The Funding Crisis of Harm Reduction – An Interview with Catherine Cook
At the 28th Harm Reduction International Conference, we spoke with Catherine Cook from Harm Reduction International about the state of harm reduction funding and the global impact of U.S. foreign aid cuts under Trump. Watch the video!
Drug Policy Prospects in Trump’s Second Term – An Interview with Ethan Nadelmann
At the 28th Harm Reduction International Conference, we had the chance to speak with Ethan Nadelmann, founder of the Drug Policy Alliance in the United States, about the present and future of drug policy during Donald Trump’s second term as president. Watch the video here!
COSS MARTE: From Convict to Cannabis CEO in New York
Watch Drugreporter’s new video about Coss Marte, a former convict who, thanks to New York State’s Social Equity Program, now runs three cannabis retail shops and a gym where he employs other formerly incarcerated individuals.
